EnPlusOne Biosciences Competitors and Similar CompaniesClear all
EnPlusOne Biosciences's competitors and similar companies include Quince Therapeutics Italy, Neurogene, Maze Therapeutics and PaxMedica.
 EnPlusOne Biosciences EnPlusOne Biosciences is a biotechnology company that develops solutions for ribonucleic acid (RNA) therapeutics. |  Quince Therapeutics Italy Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells. |  Neurogene Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). | ||
Founding Date | Founding Date 2022 | Founding Date 2007 | Founding Date 2018 | Founding Date 2018 | Founding Date 2018 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Watertown, US HQ | Locations Bresso, IT HQ Tre Torri, IT | Locations New York, US HQ Houston, US | Locations South San Francisco, US HQ Redwood City, US South San Francisco, US | Locations Tarrytown, US HQ |
Employees | Employees 2717% increase | Employees 19 | Employees 1091% decrease | Employees 121 | Employees 2100% increase |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($131.1m) (FY, 2025) | Net income ($18.3m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round $ 12m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 68.5m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 12m | Total funding raised $ 35.6m | Total funding raised $ 68.5m | Total funding raised $ 191m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Quince Therapeutics Italy
HQ
Bresso, IT
Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells.
View companyNeurogene
HQ
New York, US
Employees
109↓ 1% decrease
Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases.
View company
Maze Therapeutics
HQ
South San Francisco, US
Employees
121
Maze Therapeutics is a clinical-stage biopharmaceutical company.
View companyPaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View company